title: Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder.
abstract: Recurrence due to invasive growth is the major risk factor of transitional cell carcinoma (TCC) of urinary bladder. The interactions of hyaluronic acid (HA) and its receptors, CD44 and RHAMM, on cancer cells can promote invasion and metastasis but parallel study on these two genes in TCCs has not been available. The current work is aimed to address this issue by frozen tissue array-based immunocytochemical staining and Western blot hybridization. The results revealed that 19 out of 28 non-cancerous mucosa (68%) expressed CD44, in which 9 (33%) harbored variant exon 6 (v6). CD44 and v6 were both 5/11 (46%) in papillary, non-invasive carcinomas (pTa) and 6/14 (43%) in the tumors remained in sub-epithelial layer (pT1), while 5/29 (17%) and 3/29 (10%) in pT2-4 invasive tumors. RHAMM expression was uncommon in non-cancerous mucosa (5/28) but became frequent in pTa (9/11), pT1 (12/14) and pT2-4 (24/29) tumors. RHAMM proteins were labeled intracellularly and showed more than one isoforms. Our data further confirm the promising prognostic value of CD44 for TCC patients and demonstrate, for the first time, the correlation between RHAMM expression and malignant transformation of urothelial cells.
authors.affiliation: Cancer Institute and Laboratory of Cell Biology and Molecular Genetics, College of Basic Medical Sciences, Dalian Medical University, PR China.
authors.forename: Qing-You
authors.initials: QY
authors.lastname: Kong
authors.forename: Jia
authors.initials: J
authors.lastname: Liu
authors.forename: Xiao-Yan
authors.initials: XY
authors.lastname: Chen
authors.forename: Xiao-Wei
authors.initials: XW
authors.lastname: Wang
authors.forename: Yuan
authors.initials: Y
authors.lastname: Sun
authors.forename: Hong
authors.initials: H
authors.lastname: Li
mesh_terms: D000230:Adenocarcinoma / Q000737:chemistry* / Q000473:pathology; D017398:Alternative Splicing; D015153:Blotting, Western; D002295:Carcinoma, Transitional Cell / Q000737:chemistry* / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000378:metabolism / Q000473:pathology; D003937:Diagnosis, Differential; D016326:Extracellular Matrix Proteins / Q000032:analysis*; D005629:Frozen Sections; D006801:Humans; D018960:Hyaluronan Receptors / Q000032:analysis*; D006820:Hyaluronic Acid / Q000378:metabolism; D007124:Immunoenzyme Techniques; D009092:Mucous Membrane / Q000378:metabolism / Q000473:pathology; D009361:Neoplasm Invasiveness / Q000473:pathology*; D011230:Precancerous Conditions / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D001743:Urinary Bladder / Q000737:chemistry / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000737:chemistry* / Q000473:pathology; D019459:Urothelium / Q000378:metabolism / Q000473:pathology
chemical_list: D016326:Extracellular Matrix Proteins; D018960:Hyaluronan Receptors; C098946:hyaluronan-mediated motility receptor; D006820:Hyaluronic Acid